A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Omar Beirat
Tudor Pop
Jenna Brashear
Tudor Pop
| Share Statistics | XENE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,059.0 | $252.6 | 70% |
|
| Shares Out (Mil) | 87.3 | 52.3 | 60% |
|
| Institutional Ownership | 99.9% | 92.1% | 96% |
|
| Float (Mil) | 90.8 | 40.2 | 59% |
|
| Beta | 0.65 | 0.95 | 38% |
|
| Avg Daily Volume (000s) | 613 | 455 | 63% |
|
| Price Change (52-week) |
103.7% | 52.9% | 92% |
|
| Growth | XENE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (25.3%) | 13.6% | 2% |
|
| Net Income (5yr) | (64.4%) | (9.9%) | 5% |
|
| EPS (5yr) | (40.4%) | 16.0% | 5 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 4.9% | (15.6%) | 67% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 14 | 16 | 16 | |
| Current EPS | ($1.161) | ($4.810) | ($5.028) | |
| Month Ago EPS | ($1.161) | ($4.810) | ($5.009) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 3 | 0 | 1 | |
| Three Months Ago EPS | ($1.177) | ($4.827) | ($4.731) | |
| Year/Year Chg | (0.9%) | 10.2% | (9.0%) | |
| Financials | XENE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $38 | na |
|
| Net Income (TTM) (Mil) | ($383) | ($43) | 4% |
|
| EPS (TTM) | ($4.706) | ($1.600) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | ($306) | ($31) | 3% |
|
| Net Cash Flow (TTM) (Mil) | $429 | $5 | 90% |
|
| Long-Term Debt (Q1) (Mil) | $6 | $5 | 26% |
|
| Enterprise Value (Q1) (Mil) | $4,124 | $180 | 60% |
|
| Valuation | XENE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.53 | 2.56 | 76% |
|
| P/E | na | 19.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | XENE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 63.8% | na |
|
| Net Margin | na | (67.3%) | na |
|
| ROA | (36.0%) | (49.8%) | 15% |
|
| ROE | (37.5%) | (55.5%) | 18% |
|
| Liabilities to Assets | 3.5% | 30.3% | 1% |
|
| F-Score | 3 | 3 | 19% |
|
Xenon Pharmaceuticals Inc. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
